Victory Capital Management Portfolio holdings
AUM
$155B
1-Year Return
20.6%
This Quarter Return
-0.22%
1 Year Return
+20.6%
3 Year Return
+77.5%
5 Year Return
+161.59%
10 Year Return
+412.71%
AUM
$102B
AUM Growth
-$2.04B
(-2%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
10.73%
Holding
2,911
New
181
Increased
1,145
Reduced
1,360
Closed
133
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$195M |
| 2 |
Newell Brands
NWL
|
+$186M |
| 3 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$146M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$131M |
| 5 |
Westlake Corp
WLK
|
+$104M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$235M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$235M |
| 3 |
AutoNation
AN
|
+$189M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$175M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$132M |
Sector Composition
| 1 | Technology | 17.67% |
| 2 | Industrials | 13.82% |
| 3 | Financials | 12.32% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Healthcare | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Alico
ALCO
$261M
| $74K | ﹤0.01% |
2,152
-38
| -2% | -$1.31K |
|
|
CLVS
2627
DELISTED
Clovis Oncology, Inc.
CLVS
| $74K | ﹤0.01% |
16,696
+1,372
| +9% | +$6.08K |
|
2628
Rigel Pharmaceuticals
RIGL
$644M
| $72K | ﹤0.01% |
1,973
-65
| -3% | -$2.37K |
|
|
FSP
2629
Franklin Street Properties
FSP
$175M
| $71K | ﹤0.01% |
15,304
-763
| -5% | -$3.54K |
|
2630
Akebia Therapeutics
AKBA
$795M
| $70K | ﹤0.01% |
24,347
+883
| +4% | +$2.54K |
|
2631
Fonar
FONR
$98.2M
| $70K | ﹤0.01% |
4,539
-3,206
| -41% | -$49.4K |
|
2632
Talkspace
TALK
$447M
| $68K | ﹤0.01% |
+18,727
| New | +$68K |
|
|
QUOT
2633
DELISTED
Quotient Technology Inc
QUOT
| $68K | ﹤0.01% |
11,717
-199
| -2% | -$1.16K |
|
2634
Escalade
ESCA
$173M
| $67K | ﹤0.01% |
3,529
-5,028
| -59% | -$95.5K |
|
2635
Limbach Holdings
LMB
$1.22B
| $67K | ﹤0.01% |
+10,057
| New | +$67K |
|
2636
Oil-Dri
ODC
$955M
| $67K | ﹤0.01% |
3,804
-70
| -2% | -$1.23K |
|
|
CMRX
2637
DELISTED
Chimerix, Inc.
CMRX
| $66K | ﹤0.01% |
10,738
-1,217
| -10% | -$7.48K |
|
|
PNNT
2638
Pennant Park Investment Corp
PNNT
$469M
| $65K | ﹤0.01% |
10,057
-507
| -5% | -$3.28K |
|
|
IIN
2639
DELISTED
IntriCon Corporation
IIN
| $65K | ﹤0.01% |
3,601
+33
| +0.9% | +$596 |
|
2640
Viking Therapeutics
VKTX
$2.84B
| $64K | ﹤0.01% |
10,204
-379
| -4% | -$2.38K |
|
|
XXII
2641
22nd Century Group
XXII
$6.43M
| – | – |
0
| – | -$109K |
|
2642
Geron
GERN
$868M
| $61K | ﹤0.01% |
44,722
-1,460
| -3% | -$1.99K |
|
2643
Kopin
KOPN
$371M
| $61K | ﹤0.01% |
11,802
-568
| -5% | -$2.94K |
|
2644
Lineage Cell Therapeutics
LCTX
$290M
| $61K | ﹤0.01% |
24,113
-414
| -2% | -$1.05K |
|
|
ASXC
2645
DELISTED
Asensus Surgical, Inc.
ASXC
| $61K | ﹤0.01% |
33,038
-2,237
| -6% | -$4.13K |
|
|
BELFB
2646
Bel Fuse Class B
BELFB
$1.79B
| $59K | ﹤0.01% |
4,763
-24
| -0.5% | -$297 |
|
|
RMO
2647
DELISTED
Romeo Power, Inc.
RMO
| $59K | ﹤0.01% |
+11,981
| New | +$59K |
|
2648
Atossa Therapeutics
ATOS
$104M
| $58K | ﹤0.01% |
17,854
-614
| -3% | -$2K |
|
|
CEI
2649
DELISTED
Camber Energy, Inc
CEI
| $58K | ﹤0.01% |
+303
| New | +$58K |
|
2650
Stereotaxis
STXS
$262M
| $55K | ﹤0.01% |
10,171
-573
| -5% | -$3.1K |
|